Kei Watari Selected Research

Kei Watari Research Topics

3	Disease Progression 09/2023 - 01/2019
3	Paratuberculosis (Johne's Disease) 10/2022 - 01/2019
2	Deltaretrovirus Infections (BLV Infection) 01/2023 - 01/2019
2	Infections 01/2020 - 01/2019
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
1	Persistent Infection 09/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2023
1	Cattle Diseases (Bovine Diseases) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Chronic Disease (Chronic Diseases) 10/2019
1	Virus Diseases (Viral Diseases) 01/2019

2	Immune Checkpoint ProteinsIBA 09/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
2	ProstaglandinsIBA 10/2022 - 01/2019
2	B7-H1 AntigenIBA 01/2022 - 01/2019
2	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2019
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2019
1	Viral VaccinesIBA 03/2023
1	MucinsIBA 01/2023
1	CytokinesIBA 01/2023
1	LigandsIBA 01/2023
1	AntigensIBA 10/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	CTLA-4 AntigenIBA 10/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	AntibodiesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	Meloxicam (Mobic)FDA LinkGeneric 01/2019

2	Therapeutics 01/2022 - 10/2019